Inventor · disambiguated record
Mark Brader
Also filed as: BRADER MARK · BRADER MARK L · BRADER MARK LAURENCE
9 granted patents·13 pending applications·258 citations·filing 1995–2023
90Inventor score
Top patents by PatentIndex Score
22 records- 0196US11583504B2Stabilized formulations of lipid nanoparticlesMODERNATX INC·Filed 2017·Granted Feb 21, 2023·16 cites·25 claims
- 0295US12144895B2Stabilized formulations of lipid nanoparticlesMODERNATX INC·Filed 2022·Granted Nov 19, 2024·4 cites·21 claims
- 0395US11642398B2Factor IX polypeptide formulationsBIOVERATIV THERAPEUTICS INC·Filed 2020·Granted May 9, 2023·4 cites·19 claims
- 0493US6465426B2Insoluble insulin compositionsLILLY CO ELI·Filed 2001·Granted Oct 15, 2002·47 cites·53 claims
- 0593US6268335B1Insoluble insulin compositionsLILLY CO ELI·Filed 1998·Granted Jul 31, 2001·109 cites·24 claims
- 0688US11225650B2Methods of using FIX polypeptidesBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Jan 18, 2022·5 cites·20 claims
- 0787US6531448B1Insoluble compositions for controlling blood glucoseLILLY CO ELI·Filed 1998·Granted Mar 11, 2003·65 cites·47 claims
- 0886US10588949B2Factor IX polypeptide formulationsBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted Mar 17, 2020·8 cites·42 claims
- 0976US2023310560A1Factor ix polypeptide formulationsBIOVERATIV THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1070US2022064622A1Methods of using fix polypeptidesBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1161US2025067729A1Determination of encapsulation efficiency of lipid nanoparticlesMODRNATX INC·Filed 2022·Application pending·0 cites
- 1259US2004242460A1Stabilized acylated insulin formulationsFiled 2004·Application pending·0 cites
- 1356US2015252345A1Methods of Using FIX PolypeptidesBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 1454US2005054818A1Crystalline compositions for controlling blood glucoseFiled 2004·Application pending·0 cites
- 1548US2002082199A1Insoluble insulin compositionsFiled 2001·Application pending·0 cites
- 1648US2024238211A1Isoquinoline-stabilized lipid nanoparticle formulationsCOX JAMES C·Filed 2022·Application pending·0 cites
- 1747US2003144181A1Insoluble compositions for controlling blood glucoseFiled 2003·Application pending·0 cites
- 1847US2005176621A1Crystalline compositions for controlling blood glucoseFiled 2003·Application pending·0 cites
- 1947US2023190761A1Methylene blue stabilized mrna compositionsMODERNATX INC·Filed 2021·Application pending·0 cites
- 2040US10391062B2Dry transglutaminase compositionBRADER MARK·Filed 2009·Granted Aug 27, 2019·0 cites·26 claims
- 2139US2012269770A1Stable Preserved Compositions of Interferon-BetaBRADER MARK·Filed 2011·Application pending·0 cites
- 2228US2001041786A1Stabilized acylated insulin formulationsFiled 1995·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Brader files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →